Cite
HARVARD Citation
Baek, Y. et al. (2023). A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen. Vaccine. 41 (10), pp. 1694-1702. [Online].